Gosset Ownership
Private
Employees
~100
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Transdermal Therapeutics General Information
Transdermal Therapeutics specializes in compounding topical pain relief medications using a proprietary micelle formation process that targets nociceptors to prevent them from firing, providing pain relief without the risk of addiction or overdose associated with oral pain medications.
Contact Information
Website
Primary Industry
Non-Academic Healthcare
Corporate Office
Birmingham, Alabama
United States
United States
Drug Pipeline
Proprietary pain relief cream formulations
CommercialKey Partnerships
Partnerships with the medical community for research and discovery of pain solutions[4]
Transdermal Therapeutics Funding
No funding data available
To view Transdermal Therapeutics's complete valuation and funding history, request access »